HOME >> BIOLOGY >> NEWS
Belgian researchers explore revolutionary approach to angiogenesis

Geneva, Switzerland: A revolutionary approach to angiogenesis[1] by a team of Belgian researchers could make cancer treatment more effective at killing tumours.

Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.

The potential for exploiting tumour blood vessels has been made possible by their discovery in a study in mice that the arterioles (blood vessels less than 0.5mm in diameter) that feed tumours have the ability to contract in response to increases in pressure within their lumen (the space within the blood vessels). Equivalent sized blood vessels in healthy tissue can't do this.

"What this means is that we may have the potential to use drugs to selectively exploit these blood vessels against the tumour instead of, or before, killing them. Exploiting tumour blood vessels instead of destroying them by anti-angiogenic drugs constitutes a paradigm shift in approach to angiogenesis," Dr. Feron told a news briefing today (Thursday 30 September) at the EORTC-NCI-AACR[2] Symposium on Molecular Targets and Cancer Therapeutics.

The key to the ability of tumour arterioles to contract lies with endothelin-1 (ET-1) a peptide released in large amounts by many tumour cells, which stimulates their proliferation.

"The effect of ET-1 in tumours has been underestimated up to now," Dr. Feron said. "ET-1 has been known for years in cardiology as a very potent blood vessel constrictor. Here, we found that the myogenic tone (mechanical force) with which the tumour blood vessels contract and expand is exquisitely dependent on the endothelin pathway.

"What we did was to us
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
41-227-612-211
European Organisation for Research and Treatment of Cancer
30-Sep-2004


Page: 1 2

Related biology news :

1. Award winning researchers reveal potential new role for Glivec
2. $7.5 Million grant to Yale researchers for role of viruses in cancer
3. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
4. Joslin researchers clarify mechanisms for beta-cell formation
5. Virginia Tech researchers to release findings on Smith River Project
6. Molecular motor myosin VI moves hand over hand, researchers say
7. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
8. Emory researchers map structure of anti-cancer molecule
9. Leukemia stem cells identified by Stanford researchers
10. EURYI Award given for the first time to 25 young European researchers
11. Carnegie Mellon researchers to demonstrate autonomous robotthat will seek life in Atacama Desert

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... , ... December 04, 2018 , ... ... has been designated as a UroLift® Center of Excellence. The designation recognizes that ... UroLift System and demonstrated a commitment to exemplary care for men suffering from ...
(Date:12/5/2018)... ... December 04, 2018 , ... Biolytic Lab Performance Inc. is ... built on Biolytic’s Molecule Synthesis Platform. , Now restructured with all the ... world’s fastest in oligonucleotide synthesis, the 192c incorporates a multitude of enhancements to ...
(Date:11/29/2018)... DIEGO, Calif. (PRWEB) , ... November 29, 2018 ... ... Agilent Technologies, is excited to collaborate with the new NSF Engineering Research Center ... companies and clinical collaborators brought together to develop transformative tools and technologies for ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
(Date:12/5/2018)... , ... December 05, 2018 , ... STRmix™ – sophisticated ... to interpret – has been used to convict a Wyoming man of third-degree sexual ... Crime Laboratory used STRmix™ to test for DNA on the couch cushions on which ...
(Date:11/27/2018)... ... November 27, 2018 , ... New patients in need of a ... for treatment, with or without a referral. Dr. Myers has many years of experience ... dental implants, bridges and custom crowns. , As a dedicated cosmetic dentist ...
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of nominations for ... outstanding performance by individuals under 30 years of age. The Forbes 30 Under 30 ... and Entertainment to Venture Capital and Science. , In 2017, Visikol CEO Dr. ...
Breaking Biology Technology:
Cached News: